Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-002705
Filing Date
2025-03-11
Accepted
2025-03-11 16:10:43
Documents
118
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cara-20241231x10k.htm   iXBRL 10-K 3979476
2 EX-4.2 cara-20241231xex4d2.htm EX-4.2 11283
3 EX-19 cara-20241231xex19.htm EX-19 48807
4 EX-23.1 cara-20241231xex23d1.htm EX-23.1 14849
5 EX-31.1 cara-20241231xex31d1.htm EX-31.1 11598
6 EX-31.2 cara-20241231xex31d2.htm EX-31.2 11761
7 EX-32.1 cara-20241231xex32d1.htm EX-32.1 11095
8 GRAPHIC cara-20241231x10k004.jpg GRAPHIC 42726
  Complete submission text file 0001558370-25-002705.txt   14441220

Data Files

Seq Description Document Type Size
9 EX-101.SCH cara-20241231.xsd EX-101.SCH 97930
10 EX-101.CAL cara-20241231_cal.xml EX-101.CAL 71520
11 EX-101.DEF cara-20241231_def.xml EX-101.DEF 459854
12 EX-101.LAB cara-20241231_lab.xml EX-101.LAB 768319
13 EX-101.PRE cara-20241231_pre.xml EX-101.PRE 665231
121 EXTRACTED XBRL INSTANCE DOCUMENT cara-20241231x10k_htm.xml XML 2221530
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36279 | Film No.: 25727676
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)